Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.
Automatic multiple sclerosis lesion detection in brain MRI by FLAIR thresholding.
Liposome-encapsulated peptides protect against experimental allergic encephalitis.
Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting.
NMO-IgG positive relapsing longitudinally extensive transverse myelitis (LETM) in a seropositive HIV patient.
A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms?
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis.
IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis.
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.
Immunomodulatory activity of interferon-beta.
Communication with patients suffering from serious physical illness.
Effects of fingolimod in relapsing-remitting multiple sclerosis.
Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica.
Resistance training and vibration improve muscle strength and functional capacity in female patients with multiple sclerosis.
[Importance and treatment of spasticity in multiple sclerosis : Results of the MOVE 1 study].
Measurement and treatment of imbalance and fall risk in multiple sclerosis using the international classification of functioning, disability and health model.
Aging and multiple sclerosis.
Treatment of Neuropathic Pain and Functional Limitations Associated With Multiple Sclerosis Using an MRI-Compatible Spinal Cord Stimulator: A Case Report With Two Year Follow-Up and Literature Review.
Pelizaeus-Merzbacher disease-associated proteolipid protein 1 inhibits oligodendrocyte precursor cell differentiation via extracellular-signal regulated kinase signaling.
Elevated HSP27 levels during attacks in patients with multiple sclerosis.
Sex-related differences of cAMP-specific PDE4B3 mRNA in oligodendrocytes following systemic inflammation.
Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients.
Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis.
Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis.
Pages
« first
‹ previous
…
311
312
313
314
315
316
317
318
319
…
next ›
last »